Ве молиме користете го овој идентификатор да го цитирате или поврзете овој запис:
http://hdl.handle.net/20.500.12188/10727
Наслов: | Efficasy, safety, and pharmacokinetics results of a phase II/III, multicentre, double-blinded, randomized, cross-over study with a plasma-derived von Wilebrand Factor (WVF)/factor VIII (FVIII) concentrate (Voncento) in subjects with hemophilia A (the SWIFT-HA Study) | Authors: | A. Klukowska A. Skotnicki T. Lissitchkov V. Mamonov E. Buevich K. Kuliczkowski S. Goranov J. Kolczko S. Stankovic W. Seifert |
Keywords: | hemophilia A plasma-derived concentrate SWIFT-HA study |
Issue Date: | 2014 | Journal: | Haemophilia | Conference: | World Federation of Hemophilia (WFH) World Congress 2014, Melbourne, Australia | URI: | http://hdl.handle.net/20.500.12188/10727 |
Appears in Collections: | Faculty of Medicine: Conference papers |
Files in This Item:
File | Опис | Size | Format | |
---|---|---|---|---|
WFH 2014 World Congress Abstract book.jpg | 168.66 kB | JPEG | View/Open | |
poster Hemophilia 2014.jpg | 216.49 kB | JPEG | View/Open | |
abstract (Hemophilia 2014).jpg | 233.12 kB | JPEG | View/Open |
Записите во DSpace се заштитени со авторски права, со сите права задржани, освен ако не е поинаку наведено.